Linda T Vahdat

Years Active: 2021-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Judith R Rees, Julie E Weiss, Christine M Gunn, Heather A Carlos, Nathalie C Dragnev, Emma Y Supattapone, Anna N A Tosteson, Sally A Kraft, Linda T Vahdat, Janet L Peacock
Cancer Epidemiology in the Northeastern United States (2013-2017). Cancer research communications 3 (8) (2023)
Linda T Vahdat, Peter Schmid, Andres Forero-Torres, Kimberly Blackwell, Melinda L Telli, Michelle Melisko, Volker Möbus, Javier Cortes, Alberto J Montero, Cynthia Ma, Rita Nanda, Gail S Wright, Yi He, Thomas Hawthorne, Rebecca G Bagley, Abdel-Baset Halim, Christopher D Turner, Denise A Yardley
Glembatumumab vedotin for patients with metastatic, gpNMB overexpressing, triple-negative breast cancer ("METRIC"): a randomized multicenter study. NPJ breast cancer 7 (1) (2021)
Ying L Liu, Cecilie Liv Bager, Nicholas Willumsen, Divya Ramchandani, Naomi Kornhauser, Lu Ling, Marta Cobham, Eleni Andreopoulou, Tessa Cigler, Anne Moore, Dayle LaPolla, Veronica Fitzpatrick, Maureen Ward, J David Warren, Claudia Fischbach, Vivek Mittal, Linda T Vahdat
Tetrathiomolybdate (TM)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer. NPJ breast cancer 7 (1) (2021)

Linda T Vahdat.css-eqlu8i{font-size:small;padding-left:4px;}